Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical gentamicin during urodynamics for prevention of post-procedural urinary tract infection in spinal cord injury
ACTRN12621001587897Phase 3Recruiting
- Sponsor
- Northern Sydney Local Health District
- Start
- Oct 2021
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gentamicin in urinary tract infection (UTI) (2 arms), sponsored by Northern Sydney Local Health District. Primary endpoint: Post-procedural urinary tract infection. Started Oct 2021; status: recruiting.
02
Drugs
gentamicin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on ACTRN12621001587897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001587897.